Trial Parameters
Condition Alzheimer Disease
Sponsor Alzheimer's Light LLC
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2019-10-01
Completion 2029-10-01
All Conditions
Interventions
Boston Cognitive Assessment (BoCA)
Brief Summary
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
Eligibility Criteria
Inclusion Criteria: age 50 or older Exclusion Criteria: younger than 50 years
Related Trials
NCT06661564
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pil
View Trial →
NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitati
View Trial →
NCT06116084
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
View Trial →